Recent studies revealed that UDCA imposed anti-tumor effects through multiple pathways via targeting colon cancer cells by downregulating c-Myc protein expression, thereby suppressing proliferation and inducing apoptosis (Peiró-Jordán et al., 2012). Here, MYC is linked to colonic neoplasm.